Financials Origin Therapeutics Holdings Inc. Canadian Securities Exchange
Equities
ORIG
CA68622H1073
Investment Management & Fund Operators
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 CAD | -11.54% |
|
-14.81% | -39.47% |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2023 |
---|---|
Net sales | - |
EBITDA | - |
EBIT 1 | -2.202 |
Operating Margin | - |
Earnings before Tax (EBT) 1 | -9.46 |
Net income 1 | -9.46 |
Net margin | - |
EPS 2 | -0.3040 |
Free Cash Flow | - |
FCF margin | - |
FCF Conversion (EBITDA) | - |
FCF Conversion (Net income) | - |
Dividend per Share | - |
Announcement Date | 22/01/24 |
Balance Sheet Analysis
Fiscal Period: September | 2023 |
---|---|
Net Debt 1 | - |
Net Cash position 1 | 3.77 |
Leverage (Debt/EBITDA) | - |
Free Cash Flow | - |
ROE (net income / shareholders' equity) | - |
ROA (Net income/ Total Assets) | - |
Assets 1 | - |
Book Value Per Share 2 | 0.0300 |
Cash Flow per Share 2 | 0.0500 |
Capex | - |
Capex / Sales | - |
Announcement Date | 22/01/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+2.98% | 122B | |
+6.93% | 100B | |
+21.03% | 71.5B | |
+31.45% | 69.7B | |
+25.79% | 48.49B | |
+13.73% | 44.28B | |
+26.44% | 38.4B | |
+11.77% | 26.51B | |
+8.50% | 23.78B |
- Stock Market
- Equities
- SPLY Stock
- ORIG Stock
- Financials Origin Therapeutics Holdings Inc.